Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138789417> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W3138789417 endingPage "1455" @default.
- W3138789417 startingPage "1455" @default.
- W3138789417 abstract "Background: The incidence of invasive melanoma is rising, and approval for the first immune checkpoint inhibitor (ICI) to treat metastatic melanoma occurred in 2011. We aim to describe the epidemiology and outcomes in recent years, sociodemographic factors associated with the presence of metastasis at diagnosis, and the real-world impact of ICI approval on survival based on melanoma subtype and race. Methods: This is a retrospective analysis of the National Cancer Database (NCDB) from the years 2004–2015. The primary outcome was the overall survival of metastatic melanoma by subtype. Secondary outcomes included sociodemographic factors associated with the presence of metastasis at diagnosis and the impact of treatment facility type and ICI approval on the survival of metastatic melanoma. Results: Of the 419,773 invasive melanoma cases, 93.80% were cutaneous, and 4.92% were metastatic at presentation. The odds of presenting with metastatic disease were higher in African Americans (AA) compared to Caucasians (OR 2.37; 95% CI 2.11–2.66, p < 0.001). Treatment of metastatic melanoma at an academic/research facility was associated with lower mortality versus community cancer programs (OR 0.75, 95 % CI 0.69–0.81, p-value < 0.001). Improvement in survival of metastatic melanoma was noted for Caucasians after the introduction of ICI (adjusted HR 0.80, 95% CI 0.78–0.83, p < 0.001); however, this was not statistically significant for AA (adjusted HR 0.80, 95% CI 0.62–1.02, p-value = 0.073) or ocular cases (HR 1.03, 95% CI 0.81–1.31, p-value = 0.797). Conclusion: Real-world data suggest a 20% improvement in survival of metastatic melanoma since the introduction of ICI. The disproportionately high odds of metastatic disease at presentation in AA patients with melanoma suggest the need for a better understanding of the disease and improvement in care delivery." @default.
- W3138789417 created "2021-03-29" @default.
- W3138789417 creator A5012426504 @default.
- W3138789417 creator A5028047400 @default.
- W3138789417 creator A5034464906 @default.
- W3138789417 creator A5053832125 @default.
- W3138789417 creator A5085456199 @default.
- W3138789417 date "2021-03-22" @default.
- W3138789417 modified "2023-10-16" @default.
- W3138789417 title "NCDB Analysis of Melanoma 2004–2015: Epidemiology and Outcomes by Subtype, Sociodemographic Factors Impacting Clinical Presentation, and Real-World Survival Benefit of Immunotherapy Approval" @default.
- W3138789417 cites W1545177819 @default.
- W3138789417 cites W1970051943 @default.
- W3138789417 cites W1989121777 @default.
- W3138789417 cites W2004079062 @default.
- W3138789417 cites W2004563850 @default.
- W3138789417 cites W2025366251 @default.
- W3138789417 cites W2027367086 @default.
- W3138789417 cites W2028523748 @default.
- W3138789417 cites W2115346583 @default.
- W3138789417 cites W2131819768 @default.
- W3138789417 cites W2154391127 @default.
- W3138789417 cites W2983347147 @default.
- W3138789417 cites W2999417355 @default.
- W3138789417 cites W4231426149 @default.
- W3138789417 cites W4237866124 @default.
- W3138789417 cites W4241211595 @default.
- W3138789417 doi "https://doi.org/10.3390/cancers13061455" @default.
- W3138789417 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8004999" @default.
- W3138789417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33810182" @default.
- W3138789417 hasPublicationYear "2021" @default.
- W3138789417 type Work @default.
- W3138789417 sameAs 3138789417 @default.
- W3138789417 citedByCount "7" @default.
- W3138789417 countsByYear W31387894172022 @default.
- W3138789417 countsByYear W31387894172023 @default.
- W3138789417 crossrefType "journal-article" @default.
- W3138789417 hasAuthorship W3138789417A5012426504 @default.
- W3138789417 hasAuthorship W3138789417A5028047400 @default.
- W3138789417 hasAuthorship W3138789417A5034464906 @default.
- W3138789417 hasAuthorship W3138789417A5053832125 @default.
- W3138789417 hasAuthorship W3138789417A5085456199 @default.
- W3138789417 hasBestOaLocation W31387894171 @default.
- W3138789417 hasConcept C107130276 @default.
- W3138789417 hasConcept C120665830 @default.
- W3138789417 hasConcept C121332964 @default.
- W3138789417 hasConcept C121608353 @default.
- W3138789417 hasConcept C126322002 @default.
- W3138789417 hasConcept C143998085 @default.
- W3138789417 hasConcept C156957248 @default.
- W3138789417 hasConcept C167135981 @default.
- W3138789417 hasConcept C2777658100 @default.
- W3138789417 hasConcept C2779013556 @default.
- W3138789417 hasConcept C2994587330 @default.
- W3138789417 hasConcept C502942594 @default.
- W3138789417 hasConcept C61511704 @default.
- W3138789417 hasConcept C71924100 @default.
- W3138789417 hasConceptScore W3138789417C107130276 @default.
- W3138789417 hasConceptScore W3138789417C120665830 @default.
- W3138789417 hasConceptScore W3138789417C121332964 @default.
- W3138789417 hasConceptScore W3138789417C121608353 @default.
- W3138789417 hasConceptScore W3138789417C126322002 @default.
- W3138789417 hasConceptScore W3138789417C143998085 @default.
- W3138789417 hasConceptScore W3138789417C156957248 @default.
- W3138789417 hasConceptScore W3138789417C167135981 @default.
- W3138789417 hasConceptScore W3138789417C2777658100 @default.
- W3138789417 hasConceptScore W3138789417C2779013556 @default.
- W3138789417 hasConceptScore W3138789417C2994587330 @default.
- W3138789417 hasConceptScore W3138789417C502942594 @default.
- W3138789417 hasConceptScore W3138789417C61511704 @default.
- W3138789417 hasConceptScore W3138789417C71924100 @default.
- W3138789417 hasIssue "6" @default.
- W3138789417 hasLocation W31387894171 @default.
- W3138789417 hasLocation W31387894172 @default.
- W3138789417 hasOpenAccess W3138789417 @default.
- W3138789417 hasPrimaryLocation W31387894171 @default.
- W3138789417 hasRelatedWork W1972043246 @default.
- W3138789417 hasRelatedWork W1991879524 @default.
- W3138789417 hasRelatedWork W2011769377 @default.
- W3138789417 hasRelatedWork W2066581032 @default.
- W3138789417 hasRelatedWork W2159897971 @default.
- W3138789417 hasRelatedWork W2171435634 @default.
- W3138789417 hasRelatedWork W2337657580 @default.
- W3138789417 hasRelatedWork W2964433561 @default.
- W3138789417 hasRelatedWork W3044286377 @default.
- W3138789417 hasRelatedWork W95056088 @default.
- W3138789417 hasVolume "13" @default.
- W3138789417 isParatext "false" @default.
- W3138789417 isRetracted "false" @default.
- W3138789417 magId "3138789417" @default.
- W3138789417 workType "article" @default.